Original Research
Accepted on 18 Aug 2025
Real-world data of azacitidine for relapsed/refractory nodal T-follicular helper cell lymphoma in 11 patients
Frontiers in Hematology
doi 10.3389/frhem.2025.1638236
149 Publications
Volume 4 - 2025
Original Research
Published on 14 Aug 2025
Pre-infusion ferritin a predictive biomarker for CAR T-cell therapy in R/R multiple myeloma
Frontiers in Hematology
doi 10.3389/frhem.2025.1618331
- 610 views
Case Report
Accepted on 08 Aug 2025
Case report: Severe HHV-6-related encephalitis following anti-CD19 CAR-T therapy: No evidence of HHV-6 reactivation in transduced CAR-T cells
Frontiers in Hematology
doi 10.3389/frhem.2025.1628552
- 180 views
Review
Accepted on 01 Aug 2025
A Perfect Storm: The Deadly Intersection of Sickle Cell Disease and COVID-19
Frontiers in Hematology
doi 10.3389/frhem.2025.1651089
- 349 views
Case Report
Accepted on 28 Jul 2025
A case of Intravascular large B-cell lymphoma and related literature review
Frontiers in Hematology
doi 10.3389/frhem.2025.1639726
- 277 views
Case Report
Published on 24 Jul 2025
Balance and management of CRS and infection following CD19-targeted CAR T-cell therapy in primary refractory high-grade B-cell lymphoma: a case report
Frontiers in Hematology
doi 10.3389/frhem.2025.1616504
- 650 views
Review
Published on 16 Jul 2025
The therapeutic perspective of relapsed/refractory Waldenström Macroglobulinemia: what comes next?
Frontiers in Hematology
doi 10.3389/frhem.2025.1624046
- 865 views
Case Report
Published on 15 Jul 2025
Co-occurrence of AIDS and acute promyelocytic leukemia: a case report and review of the literature
Frontiers in Hematology
doi 10.3389/frhem.2025.1527938
- 585 views
Original Research
Published on 14 Jul 2025
Soluble immune checkpoint landscape in sickle cell disease links systemic inflammation, autoimmunity, and pain
Frontiers in Hematology
doi 10.3389/frhem.2025.1580009
- 677 views
Brief Research Report
Published on 11 Jul 2025
The “added value” of enrolling hematological patients in clinical trials: a single-center experience
Frontiers in Hematology
doi 10.3389/frhem.2025.1613099
- 569 views
Review
Published on 23 Jun 2025
Advances in Chimeric Antigen Receptor T-cell therapy for hematologic malignancies and autoimmune conditions: a review of the 2024 American Society of Hematology Annual Meeting
Frontiers in Hematology
doi 10.3389/frhem.2025.1610794
- 939 views
Case Report
Published on 23 Jun 2025
Case report: Clinical characteristics and genetic analysis of a familial platelet disorder associated with RUNX1 gene mutation
Frontiers in Hematology
doi 10.3389/frhem.2025.1608314
- 562 views
Case Report
Published on 23 Jun 2025
Case Report: Contrasting outcomes and use of desmosine to monitor two patients treated with plasma cell-directed chemotherapy for gammopathy-driven pulmonary elastolysis in acquired cutis laxa
Frontiers in Hematology
doi 10.3389/frhem.2025.1502322
- 363 views
Mini Review
Published on 19 Jun 2025
Understanding therapy-related AML: genetic insights and emerging strategies for high-risk patients
Frontiers in Hematology
doi 10.3389/frhem.2025.1609642
- 1,019 views
Case Report
Published on 18 Jun 2025
Successful management of acute promyelocytic leukemia in the third trimester of pregnancy: a case report and review of the literature
Frontiers in Hematology
doi 10.3389/frhem.2025.1553336
- 939 views
Case Report
Published on 16 Jun 2025
Case Report: Expanding the ocular horizon: subperiosteal orbital hematoma and Roth spots in known case of sickle cell disease
Frontiers in Hematology
doi 10.3389/frhem.2025.1558509
- 800 views